Results 51 to 60 of about 478,084 (316)

Distribution Fitting.

, 2012
Distribution fitting for the brain cancer dataset for RMA (top) and DChip (bottom) normalized data. The three best-fit curves are superimposed on the histogram, and the normal distribution curve is included for comparison. The specific parameters for the
Robert J. Weil (123848), Nicholas F. Marko (123844)   +1 more
core   +1 more source

On Estimation of α-Stable Distribution Using L-Moments

Fractal and Fractional
The family of stable distributions and, in particular, the α-stable distribution increases its applicability in engineering sciences. Examination of industrial data shows that originally assumed Gaussian properties are not so often observed.
Xunzhi Liao, Paweł D. Domański
doaj   +1 more source

Uncertainty inherent in empirical fitting of distributions to experimental data

International Journal of Metrology and Quality Engineering, 2013
Treatment of experimental data often entails fitting frequency functions, in order to draw inferences on the population underlying the sample at hand, and/or identify plausible mechanistic models.
Barbato G., Genta G., Levi R.
doaj   +1 more source

Optimization of Probability Density Functions Applicable for Hourly Rainfall

Atmosphere, 2023
In order to improve the calculation accuracy of the rainfall probability distribution in related applications, this study aimed to select a theoretical function from applicable functions for three classes of the class-conditional probability density ...
Tieyuan Shen, Yiheng Xiang
doaj   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro, Freda Qi, Karen Colwill, Alina D. Dorogy, Ying Liu, Michelle Science, Anne‐Claude Gingras, James M. Rini, Sumit Gupta, Sarah Alexander, Shelly Bolotin, Tania H. Watts   +11 more
wiley   +1 more source

Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications. [PDF]

, 2006
Severe adverse events (SAEs) following ivermectin treatment may occur in people harbouring high Loa loa microfilarial (mf) densities. In the context of mass ivermectin distribution for onchocerciasis control in Africa, it is crucial to define precisely ...
Pion, Sébastien, Kamgno, J., Filipe, J.A.N., Gardon, Jacques, Pion, SDS, Boussinesq, Michel, Basanez, M.G., Basáñez, M-G, Boussinesq, M, Gardon, J, Filipe, JAN, Kamgno, J   +11 more
core   +1 more source

Distribution (%) of the best fitting cumulative distribution function for individual dose realizations.

, 2023
Distribution (%) of the best fitting cumulative distribution function for individual dose realizations.
Bruce A. Napier (2625124), Marina O. Degteva (2625127), Elena A. Shishkina (11565167), Dale L. Preston (16814272)   +3 more
core   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook, Veerain Gupta, Nicholas J. Clark, Vijay Rings, Lauren E. Corona, Douglass B. Clayton, Daniel J. Benedetti   +6 more
wiley   +1 more source

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási, Bernadett Borbála Huszti, Gábor Barna, Marko Kavcic, Janez Jazbec, Lennart Lenk, Vera Münch, Sophia Polychronopoulou, Ágnes Márk, Maria Thastrup, Lüder H. Meyer, Kjeld Schmiegelow, Cornelia Eckert, Christina Halsey, Dániel J. Erdélyi   +14 more
wiley   +1 more source

Distribution fitting results for experiments in Table 2.

, 2022
Distribution fitting results for experiments in Table 2.
Ruiying Li (446313), Yeqing Song (623024)   +1 more
core   +1 more source